載入...
A Phase I Study of a Tropism Modified Conditionally Replicative Adenovirus (CRAd) for Recurrent Gynecologic Malignancies
PURPOSE: To determine the maximum tolerated dose (MTD), toxicity spectrum, clinical activity, and biological effects of the tropism-modified infectivity-enhanced CRAd, Ad5-Δ24-RGD, in patients with gynecologic malignancies. EXPERIMENTAL DESIGN: Cohorts of eligible patients were treated daily for 3 d...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
2010
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2970766/ https://ncbi.nlm.nih.gov/pubmed/20978148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-0791 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|